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OVERVIEW
Fibrin is ubiquitous in inflammatory disease processes and is thought to
be rapidly metabolized by a variety of fibrinolytic enzymes (e.g. plasmin)

producing, at the site of inflammation, a wide range of degradation products.
These

products of fibrinogen metabolism (designated Fibrinogen Derived

Factors, or FDFs) have been shown to possess wide ranging biological
activities in vitro and in vivo. 63

For example, FDFs have been shown to

affect coagulation, 5 vasopermeability, 22 endothelial cell

integrity,64, 65

inflammatory cell chemotaxis, 21 as well as lymphocyte proliferation and
antibody production. 20 In light of the immunomodulatory effect that FDF’s
have on other inflammatory cells (e.g.

lymphocytes), our laboratory has

hypothesized that FDFs also modulate neutrophil function in vitro and in vivo

(see Figure l). It was hypothesized that host and/or bacterial derived factors

present at a disease site generate specific FDFs which are capable of altering
the PMN (neutrophil) causing down regulation or suppression of neutrophil

function.

For the purpose of this thesis, "down regulation" will refer to

suppressing neutrophil function and "up regulation" will refer to augmentation

of neutrophil function.

The resulting "suppressed" neutro.hils may be

deficient in phagocytosis and killing of bacteria which may result in the

proliferation of bacteria at the diseased site.

Fibrin deposition increases

from the resultant tissue damage, and the cycle repeats itself.

With this

hypothesis in mind, the general objective of this study was to determine if

FDFs known to be produced locally in an inflammatory lesion can modulate
neutrophil function and host defense in vivo.
Since no systematic investigations to date have been undertaken to

study the effects of FDFs on neutrophil function, short term goals or" the

present studies were developed to evaluate the in vitro effects of F DFs on
key neutrophil functions involved in host defenses. Although there are a wide
number of neutrophil functions that contribute to host

defense, the direct

microbicidal activity of the neutrophil is central to host defense.

Thus,

initial experiments focused on determining the direct effect of FDF on

microbicidal activity. Preliminary data generated at the outset of this study

demonstrated the ability of FDF to significantly inhibit P MN microbicidal

activity.
PMN microbicidal activity may be divided into adherence dependent

phenomena,

oxygen

dependent

microbicidal

phenomena,

and

oxygen

independent microbicidal phenomena, and oxygen independent microbicidal

phenomena. Therefore in order to gain insight into the mechanism of FDF
inhibition of microbicidal activity, the effect of FDF on adherence,

phagocytosis (adherence dependent),

H202, chemiluminescence (oxygen

dependent), and degranulation (oxygen independent) were studied.
The long term goal of this project is to determine the role of FDFs in

inflammation and host defense in general and in human periodontitis

specifically.
Periodontal disease is an excellent model for studying host-parasite

interactions in a chronic

inflammatory

lesion.

Organisms capable of

producing fibrinolytic enzymes have been found in increased numbers in
periodontal

disease.77

Fibrin has been found in diseased periodontal disease

tissues 54 and in gingival fluid obtained from perodontis lesions. 30

Moreover,

FDF have not been detected in clinically normal tissues. 30 Since neutrophils
have

been

shown

to be

essential

in

preventing the progression of

inflammatory periodontal disease, 48 it is hypothesized that the production of

F DF’s by bacteria inhibit neutrophil function in periodontal disease allowing
for disease progression. The identification of specific FDF’s will not only
provide insight into the mechanism involved in inhibition of neutrophil

function, but may provide a useful diagnostic tool in identifying local
inflammatory lesions in which connective tissue destruction is occurring.
Finally, it is hoped that i_n vitro findings can be extended to a relevant i_.n vivo
disease model.

FIGURE
Hypothetical Model for the Role of FDF

in Regulating Leukocyte Function During
Inflamation and Host Defense

Microbes Present At
Diseased Site
Bacterial

mes

Proliferation of Bacteria

=

=_-

Increased"
1.tissue damage
2.fibrin deposition

FD.I=

" .P.MN

Binding to

Down-regul

AItered Neutrophil

-’

Membrane

REVIEW OF THE LITERATURE

AND RATIONALE
Fibrin is a ubiquitous protein found in virtually all in inflammatory

processes,

e.g.

renal

disease,21

disseminated intravascular

transplant

rejection

coagulation,5 neoplasia,12

phenomena, ll

and inflammatory

periodontal disease 30 to name but a few. Previously, fibrin was thought to

fu.nction

primarily as a hemostatic plug, with past investigations dealing

primarily with the physical manifestations of fibrin deposition, e.g., fibrin’s
role in hemostasis, tissue repair and limiting the spread of microorganisms

Interestingly, relatively little work has been done

from the disease site.

concerning the biological role
metabolism.

of peptides

This is surprising in light of:

derived

from

fibrinogen

l) interrelationships that have

been shown to exist between the coagulation system and inflammatory

processes,71

2) the high concentration of these peptides found in many

inflammatory lesions43 and 3) evidence establishing that these peptides do
have effects in vivo and

i__n vitr.o. For example, during acute inflammatory

reactions in models of acute respiratory disease, 46 a reduction of pulmonary

edema has been seen following fibrinogen depletion. In chronic inflammation,

a role for fibrin has been suggested through the use of anticoagulants, e.g.
heparin has been shown to inhibit intraocular tuberculin hypersensitivity. 79
This observation has been supported by other studies that demonstrate that
the anticoagulants ameliorate the effects of delayed type hypersensitivity

reactions. 13

In addition, the typical induration present in delayed type

hypersensitivity

reactions

afibrinogenem ia. 15

is

not

seen

in

individuals

with

a

rare

Anticoagulants and genetic defects in fibrinogen

production were used in the studies cited above to limit fibrin accumulation

and FDF production, however,

n

an inflammatory reaction i_.n vivo FDF

production and their concentration is dependent upon the balance of protease
and anti-protease systems.
Thus a variety of FDFs may be obtained from thrombin, plasmin, or

cellular derived protease metabolism of fibrinogen.

A brief review of the

general pathways of fibrinogen metabolism and the biological activities
associated with their metabolites is provided below.

Fibrin Metabolism
The formation of fibrin from its precursor fibrinogen is the result of a

complex system of regulatory zymogen enzymes which function as serine

proteases.

These zymogen enzymes, or coagulation factors, have been

assigned Roman numerals I-XIV, and are divided functionally into two
pathways;

the intrinsic pathway and the extrinsic pathway (see figure 2).

The instrinsic pathway and the extrinsic pathways are linked through their

conversion of Factor X which is the first key reaction leading to the
formation of a clot. The other two key reactions are:
thrombin and 2) the formation of fibrin.

l) the formation of

Clotting involves an interplay

between the two pathways and each is needed for proper clotting.

The

intrinsic pathway is activated by exposure of instrinsic blood components

(Factor XII) to a negatively charged surface (subendothelial collagen,
phospholipids). The extrinsic pathway is activated when trauma to a blood
vessel releases a lipoprotein called Tissue Factor.

A complex of Tissue

Factor and Factor VII then catalyze the activation of Factor X, which along
with Factor V and Platelet Factor 3 cleaves prothrombin to produce

thrombin. The enzyme thrombin is responsible for the generation of fibrin

from its precursor fibrinogen.

Fibrinogen is comprised of 3 pairs of

FIBRINOGEN

Thrombin

FIBRIN

Plasmin

HIGH MOLECULAR WEIGHT FRAGMENTS

Plasmin

LOW MOLECULAR WEIGHT FRAGMENTS
Figure 2" Fibrinogen Metabolism Which Produces
Fibrinogen Derived Factors

polypeptide chains designeated A, B B

and .46

Thrombin cleaves four

arginine-glycine bonds in fibrinogen releasing four peptides: an "A" peptic]e
from each alpha chain, and a B peptide from each of the two

B

chains. These

peptides are referred to as fibrinopeptides, while fibrinogen devoid of these
peptides is referred to as fibrin monomer. Fibrin monomers aggregate endto-end and side-to-side and polymerize, being held together by hydrophobic

bonds, and this fibrin is referred to as soluble fibrin.

At the time of

fibrinopeptide release, thrombin activates Factor XIII (i.e., fibrinoligase)
which replaces the hydrophobic bonds on the polymerized fibrin with covalent
bonds forming an insoluble fibrin polymer.

The coagulation cascade, if

unregulated, could lead to excessive fibrin formation, pathologic thrombiosis,
and tissue damage.

Fibrin(ogen) metabolism is regulated by a variety of

proteases and antiprotease which controls fibrin deposition and the
fibrinolysis.
Control of fibrin deposition is achieved by protease inhibitors such as

anti-thrombin Ill which blocks most of the serine proteases in the coagulation

cascade.

Other minor inhibitors of the coagulation cascade include: anti

trypsin, c2 macroglobulin, and C l esterase inhibitor. If these inhibitors fail
to prevent excessive fibrin formation, then the fibrinolytic system plays a
major role in removing

p})tentially

vasculature and/or tissues.

harmful fibrin deposits from the

Fibrinolysis can be considered to be the

physiologic counterpart to the process of fibrin deposition.

Its function,

along with the inhibitors mentioned above, is to limit the accumulation of
fibrin. The major enzyme responsible for fibrinolysis is plasmin and it exists
in plasma as its precursor plasminogen. P lasminogen is present in serum as a

single polypeptide chain with a molecular weight of 90,000.

The principal

site of plasminogen synthesis is the liver although some controversy exists

concerning other sources 18. Plasminogen is converted to plasmin through the
enzymatic cleavage of two peptide bonds liberating two peptide chains; a

light chain and a heavy chain; the active site of plasmin is located on the

Numerous activators of plasminogen exist and the most

light chain.

important physiologic pathways for plasminogen activation are the Hageman

factor pathway and endothelial synthesis of plasminogen activator.

The

Hageman factor pathway functions through the interaction of factor XIIa
with a plasminogen proactivator. This interaction leads to production of an

activator that converts plasminogen to plasmin which then degrades fibrin.
Tissue plasminogen activator

(t-PA), secreted by a variety of cells including

maerophages nd vascular endothelial cells, is a single polypeptide chain with
a molecular weight of 70 kDa. The rate of plasminogen activation by t-PA

increases several hundred fold by the presence of fibrin suggesting the
formation of a t-PA-fibrin complex.

Plasmin has wide ranging enzymatic

activity and has an equal affinity for fibrin and fibrinogen. Due to its wide

ranging enzymatic activity, plasmin is capable of degrading coagulation

factors and activating complement. The degradation of coagulation factors
can lead to hemorrhage, and the activation of complement has multiple
effects such as increased vascular permeability and red blood cell hemolysis.
Since plasmin has multiple biological activities and its precursor is

found in most biologic fluids, 6 regulation of plasmin activity must occur.
Inhibitors

of

plasmin

activity

include

alpha2-antiplasmin

alpha 2-

macroglobulin and Cl esterase inhibitor. The lysis of fibrin and fibrinogen by
plasmin proceeds by cleavage of the corboxy terminal of the A a chain. The

process continues with destruction of the

B

chain and finally the

chain is

i0

degraded. 18 This process of enzymatic dgestion results in the production of
four clinically recognized FDFs, the X,

Y, D and E fragments, in order of

production as well as low molecular weight peptides.

The low molecular

weight peptides are not well defined as to their structure, however they have
been shown to possess biologic activity. 20
The degradation of fibrin and fibrinogen can occur by the action of

enzymes other than plasmin.

For example, inflammatory cells such as

neutrophils and macrophages are capable of degrading fibrin, producing FDFs.
Neutrophil derived elastase cleaves fibrin, producing peptides different from
those produced by plasmin.

Thus fibrinogen can be metabolized by a wide

variety of cell-derived proteases producing numerous large and small peptides
that have been shown to possess biologic activities.

B.,iological Ef.feets of FDF
Fibrinogen derived factors have been shown in the literature to have a
variety of biological effects i_.n vivo and i_n vitro. Provided below is a brief
review of the effects of FDF on l) coagulation, 2) vasopermeability and 3)

leukocyte/lymphocyte function.

Information pertaining to microbicidal

degradation of fibrinogen and its possible relationship to periodontal disease
is also provided.
This review is not

only provided

for the purpose of a general

background, but to provide the foundation for the hypothesis of the role of

FDF in regulating PMN function. For example, information pertaining to the
effect of FDF on cells and

factors involved in coagulation and

vasopermeability was included due to the importance of these processes in
inflammation and host defense. Background information is provided on the

ability of bacteria to degrade fibrinogen producing FDF was cited to suggest

Ii

a link between bacterial derived FDF and modulation of host defense.

Finally, evidence pertaining to FDF and periodontal disease was included to
show how these factors may affect an inflammatory disease of bacterial

origin.

,FDF and Coagulatio,n
Inhibition of coagulation is important in diseases where fibrinolysis

predominates, e.g., carcinomas, and disseminated intravascular coagulation.

In the case of disseminated intravascular coagulation (DIC), the presence of
FDF’s determines the clinical signs and symptoms of this condition. In DIC,
if fibrinolysis is dominant, hemorrhage occurs. 5 FDF’s have profound effects
on the coagulation system and have been shown to be anti-coagulants

i_.n

vivo. 6 These studies demonstrated that FDFs directly inhibited coagulation
by l) interfering with fibrin monomer polymerization and 2) inducing a defect
in platele t function.

.F. DF and.Vasopermeability
In addition to their effects on coagulation, FDF’s have direct effects on
the

vasculature.

ermeability3,63, 64

FDF’s

have

been

shown

to

ncrease

and induce isolated arterial contraction. 7

vascular

A series of

studies have described the isolation and characterization of peptides which
have vasopermeability effect in vivo. These peptides have been identified as

Aa 224-324 from the middle region of the A a chain and B 43-47.26,3, 4

In a series of reports, Kreutzer and colleagues have shown that FDF’s
related to

Moreover,

BI-42 can induce

vascular endothelial cell injury i_.n vitro.63,64, 65

these F DF’s were shown to injure vascular endothelial cells in

aorta organ cultures, 17 and to induce vasopermeability in

skin.41

These

findings are significant when one considers the role of the vasculature in

12

inflammatory reactions. Endothelial cells are intimately involved with the
regulation of vascular permeability. An increase in vasopermeability is one

of the first signs of inflammation allowing for the exchange of inflammatory
cells from the vasculature to a tissue site. This increase in vasopermeability
is followed by recruitment of cells to the site of inflammation. Since fibrin
is present at high concentrations at many inflammatory sites, its effect on

inflammation or inflammatory cells may be significant.

Effect of FDF On .Leukocyte/Lymphocyte

Fun.ction

As mentioned above, recruitment of inflammatory cells to the site of
inflammation is necessary for the process of inflammation to occur. FDF’s
have been shown to affect leukocyte/lymphocyte function.

For example,

FDF’s (BB 30-43) have been shown to induce neutrophil chemotaxis in skin.
Leukocyte accumulation at two hours was significantly greater with injection
of F DF’s than with injection of leukotriene B4. 68 The above report suggests
that peptides that are cleaved early

n

the formation of a fibrin clot (B 30-

43) enhance chemotaxis of neutrophils.

Girmann et al. first suggested that

FDF derived from the plasmic cleavage of fibrinogen suppress the immune

esponse

in vivo, and inhibit the response of blood mononuclear cells to

phytohe rn aglu t inin. 27

Edgington,27, 20

This

who found

work

has been

extended by

Saldeen

and

hat FDF’s inhibit the proliferative response of

lymphocytes to mitogens and to allogeneic cell stimulation. Inhibition was
dose specific and could be elicited

before, at the time of, or as late as 4

hours after mitogen stimulation.

I_.n vivo

experiments have demonstrated that low molecular weight FDF

can suppress cell mediated immune reactivity 61 and are associated with

enhancement of tumor growth in BALB/c mice 62.

Recently, receptor

13

mediated binding of large molecular weight FDFs to macrophages has been

described 59. The binding of FDFs to microphages has also been shown to
increase production of the monokine Hepatocyte Stimulating Factor. 51

Therefore, the binding of FDF to macrophages may represent a feedback
regulatory mechanism by which fibrinogen synthesis is regulated.

Fibrinogen Metaboli.sm and

Mcrob...e.s

The effect of FDF’s on leukocyte/lymphocyte function is diverse, i.e.

chemotaxis and lymphocyte responses to mitogens.

Clearly, the body of

literature to date supports the role of FDF’s as modulators of local

inflammatory reactions.

If FDF’s

function

as local modulators

of

inflammation, it is not unreasonable to hypothesize that bacteria have
developed ways of using the regulatory effects of FDF’s to their advantage.

Classically fibrin has been thought to wall-off an inflammatory lesion
and act as a barrier to the spread of microorganisms contained in the

lesion. 63 IIowever, very little work has examined the identity of FDF
produced by bacterial enzymes and the effects of these products on host

inflammatory cells.

This is surprising in light of l) the growing body of

literature demonstrating that FDF’s have effects on inflammatory cells, and

2) the ability of many pathogens to synthesize extracellular factors that
produce FDF’s. Streptokinase, produced by

B hemolytic

streptococci, is the

most widely known factor responsible for FDF production. Streptokinase is a

single chain protein of molecular weight

47,000.9

Streptokinase functions by

forming a complex with plasminogen and thereby inducing a conformational
change. This conformational change exposes an active enzymatic site within
the complex which may cleave an arginal-valine bond in other plasminogen

molecules forming

plasmin.9 Other bacteria (in addition to B hemolytic

Stre p)

14

produce fibrino(geno)lytic enzymes. Oral bacteria such as Bacteroides

0ralis

produce a streptokinase-like .molecule which acts indirectly by activating

plasminogen. 53

Bacte.iodes gingivalis

(an organism associated with

periodontitis disease sites) possesses a membrane-bound protease which

causes fibrinolysis. 53 Treponema

dentic0!a

produces an enzyme which acts

directly on fibrin to effect lysis. 53 In a recent study, a correlation was found
between possession of fibrino(gene)lytic activity and the presence of

microorganisms in inflammatory disease sites. Bacteria were isolated from
deep periodontal pockets and the predominating strains isolated were tested

for fibrino(geno)lytic activity. Fusobacterium, Bacteroides and Actinomyces
species all exibited fibrino(geno)lytic activity. 77 These organisms are found
in increasing numbers in adult periodontitis. 69

These findings suggest that

fibrino(geno)lytic enzymes produced by bacteria may function as virulence

factors. However, to discuss a possible role for bacterial factors related to
fibrinogen metabolism in the progression of chronic disease processes an
experimental model must be selected, periodontal disease represents such a
model.

Fibrinogen Metabolism and Periodontal Disease
Periodontal disease is an excellent prototypical model for studying and

illustrating

host-parasite-fibrinogen

metabolism interrelationships.

It is

ideally suited becaus the lesions and disease activity are localized (fibrin

exerts its modulating effects locally), the lesions are easily accessible, and
documented animal models

exist.55 Regardless of these advantages and the

almost universal presence of fibrin in inflammatory lesions, little work has
been done to examine FDF’s role in periodontal disease. Provided belov is a

15

brief review of what is known about FDF’s and host-parasite relationships in
periodontal dsease.

Bacteria, which are suspected periodontal pathogens, have been shown
to possess the ability to degrade fibrin (as dscussed above). Fibrin has been
shown to be present in periodontal pockets, and has been seen lining the

pocket wall in close proximity to emigrating neutrophils.54

In related

studies, neutrophil enzymes have been shown to be capable of degrading

fibrinogen.28 A limited

number of studies have looked at the capability of

epithelial cells lining the periodontal pockets to cause fibrinolysis.

These

cells lining the pocket have been shown to secrete plasminogen activators and

cause fibrinolysis in humans and a number of animals.70, 45

Plasminogen

activator synthesis has been reported to be a function of cell keratinization
and cell turnover. 70 Epithelial cell production of plasminogen activators may
be of significance in the pathogenesis of periodontal disease due to l)

plasmin’s ability to activate complement, and 2) fibrinolysis produces FDF’s.

One study has looked at the presence of FDF’s in the gingival fluid of healthy
patients and those with periodontitis. 30

patients with periodontitis.

FDF’s were found in 12 of 14

FDF’s were not found in patients who were

clinically healthy. 30 Therefore, the necessary enzymes (bacterial, neutrophil
or tissue) and substrates

[fibrin(ogen)]

are present in periodontal pockets for

the production of FDF’s.

It is possible that the association between FDF’s and periodontal disease

may be due to effects that FDF’s have on neutrophil function. To date, no
studies have investigated the effects of FDF’s on neutrophil microbicidal

functions.

Neutrophils are present in the gingival sulcus, and existing

evidence suggests that they play a protective role. 48

Evidence to support

16

this role is based on peridontal disease severity in patients afflicted with

neutrophil abnormalities such Chediak-}ligashi syndrome and neutropenic

states.29,14 Patients with defects in neutrophil function, or possessing
decreased numbers of neutrophi]s exhibit early severe periodontal destruction
and loss of teeth. 14

In addition, it has been reported that the phagocytic

activity of neutrophils in severe periodontal lesions is diminished locally. 49

Therefore FDFs have been shown to be associated with a disease process in
which the local control of neutrophil function is of primary importance.

HYPOTHESIS AND SPECIFIC AIMS

As was presented in the previous section, FDF have been shown to be
associated with a wide range of disease processes in which host defense is of

primary importance.

Previous investigations of the effects of F DF on

immunologic cell function have focused on the lymphocyte. 18

Since the

neutrophil plays an important role in host defense, the present study was
undertaken to determine the effect of FDF on P MN function in vitro.

In light of the fact that FDF have been shown to affect lymphocyte
function

n

yitro and i__n vi_y.vo 18, 61 the following general hypothesis was

developed: that local generation of FDF by either tissue or microbe derived

proteases can result in the down regulation of neutrophil function i.e.
suppression. This down regulation of neutrophil function result in depressed
host defense with resulting proliferation of bacteria at a disease site. This

increase in bacterial proliferation results in increased tissue damage, fibrin

deposition and the cycle repeats itself.
To begin to test this hypothesis, the effect of FDF on P MN microbicidal
activity was studied. Preliminary data were developed at the outset of this
study which demonstrated the ability of low molecular weight peptides (FDF)
derived from the plasmin digestion of fibrinogen to inhibit P MN phagocytosis

and killing of bacteria. Therefore to dissect the molecular/cellular basis of

FDF activity, specific aims were developed to systematically study the
effect of FDF on those functions involved in microbicidal activity. Functions
involved in PMN microbicidal activity can be divided into adherence

dependent functions (binding of a microbe to the P MN, phagocytosis) oxygen
dependent functions

(H202 production)

and oxygen independent functions

(degranulation). The effect of FDF on chemotaxis was studied because this

17

18

function is directly related to host defense and microbicidal activity. Those

specific aims are as follows"

Specific Aims
SPECIFIC AIM l:

To determine the effect of FDF on neutrophil
functions involved in host defense.

Question 1:

What is the Effect of

FDF on PMN chemotaxis?

Study l:

Effect of FDF on chemotaxis

Study 2:

Are FDF effects reversible

Question 2:

What is the effect of FDF on Fc receptor function and

phagocytosis?

Study 3:

Microscopic

quantification of adherent opsonized

sheep red blood cells

Study 4:

Microscopic quantification of phagocytosed sheep red
blood cells

Question 3:

What are the effects of FDF on oxygen dependent

microbicidal activity of leukocytes?

Study 5:

Chem ilum inesc ence

Study 6:

H202 production

Question 4:

What

are

the

effects

of

FDF

on

leukocyte

degranulation?

Study 7:

Release of granule components extracellularly
Quantification of lysozyme

Study 8:

Primary vs. secondary granules
a.

B glucuronidase quantification as a primary
granule marker

b.

Lactoferrin

quantification

as

a

secondary

granule marker

SPECIFIC AIM 3:

To characterize the identity of FDF involved in the
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METHODS
Isolation and Purification of Fibrinogen

The method used to isolate and purify fibrinogen from plasma was a

modification of that employed by Doolittle, et
plasma was

obtained

(corresponding to

(Red

commerc|al

Cross,

al.19

Farmington,

(see Figure 3).
CT)

and

Fresh

fraction

I

preparations) was precipitated by the addition

of 0.22 volumes of cold 50% ethanol in 0.55 M trisodium citrate pH 7.1 while
lowering the temperature to-3C. After centrifugation, the precipitate was
washed with 0.5 original volumes of 7% ethanol pH 6.5 at-3%.

The

precipitate was then dissolved in 15 m M phosphate buffer and the pH and
ionic strength were adjusted to 7.8 and 6.9 m.mho respect}vely.

The

solubilized fibrinogen was then passed through a DEAE ion exchange

chromatography disk (AMF, Cuno, Meriden, CT) which has been demonstrated
to remove complement component C3 from plasma (Kreutzer unpublished).

After ion exchange chromatography, the fibrinogen was placed on a gelatin
sepharose column to remove fibronectin contamination. The void volume was
collected and cooled to 0C and "cold insoluble material" removed

by

the

addition of cold 20% ethanol to a final concentration of 2%. Centrifugation

removes a mucous like precipitate. Addition of more 20% ethanol to a final
concentration of 8% results in the precipitation of fibrinogen used in this

study.

Assessment of Fibrinogen Purity
Fibrinogen preparations were assayed for contaminants using: l) ELISA
to measure C3, C5 contaminations; 2) SDS-PAGE; 3) SDS-PAGE reduced

fibrinogen for fibronectin contamination; and total amino acid analysis.
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Plasma or Fraction I Fibrinogen

Precipitation with .22 volumes of cold
5 0% ethanol -3

centrifuge and collect pellet
Wash with .5 original volumes
7% ethanol pH 6.5 -3

centrifuge and collect pellet
Dissolve in 15 mM phosphate
buffer pH 7.8; ionic strength 6.9 mmho

DEAE ion exchange
Removal of C3
Gelatin

pharose
Removal of fibronectin

Addition of cold 20% ethanol to
a final concentration of 2%

Addition of 20% ethanol to a
final concentration of 8%

Precipitation of ibrinogen used in
experiments

Figure 3- Protocol for Fibrinogen Purification
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Preparation of FDFs

.

Purified fibrinogen was dissolved in 0.02 M Tris-HCl 0.1 M NaCl pH 7.8

to a final concentration of 4 mg/ml and warmed to 37

Plasmin (Sigma, St.

Louis, M O) (0.02 u/ml) was added to the fibrinogen and the mixture was
incubated for 18 hours stirring at 37 C.

Aliquots were saved at l rain, 15

min, l hour, 5 hours, 18 hours, and frozen at-80

PAGE.

for analysis using SDS-

Following the 18 hour incubation, the large molecular weight

fibrinogen was separated from the plasmin generated peptides using an
amicon ultrafiltration unit. The unit contained a membrane which excludes

proteins > 30,000 M.W. The plasmin generated peptides 30,000 M.W. were

lyophylized and stored at-20C for use in the experiments.

Reeonstitution and, Standardizatign,, Of FDF, Pe[tid ,es
The lyophilized peptides were reconstituted by the addition of disti.lled

water (see Figure 4). Peptide concentration was determined by absorbance at
212 nm, since standard protein assays are unable to quantify small peptides
accurately (212 nm is the region where peptide bonds absorb u.v. light). A

buffer of 0.02 M tris; 0.1 M NaCl, pH 7.8 was used to blank the instrument.
The peptide samples were adjusted to an abosrbance of 30, 15, and 7.5

absorbance units for use in experiments. Addition of 0.2 ml of

30:15

and 7.5

absorbance units to a 0.5 ml PMN solution resulted in a final concentration of

8.6, 4.3, and 2.15 absorbance units respectively. A 0.2 ml aliquot of a 30
absorbance unit solution was found to contain 260 pg/ml of FDF upon amino
acid analysis and corresponded to a starting solution of 6 mg/ml of

fibrinogen. These concentrations are biologically relevant.

PURIFIED FIBRINOGEN
-complement removed
-fibronectin removed
18 HOUR PLASMN DIGEST

AMICON FILTRATION

PEPTIDES < 30,000 MW

LYOPHILIZATION

RECONSTITUTION OF
PEPTIDES USED IN EXPERIMENTS

STANDARDIZATION OF
PEPTIDE CON CENTRATION
USING ABSORBANCE AT 212 nm

Figure 4:

PROTOCOL FOR THE PRODUCTION OF LOW MOLECULAR
WEIGHT F DF
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Preparation of Control Small Molecular Weight Peptides

Small molecular weight peptides derived from BSA were prepared to
rule out any non specific effect small peptid.es might have on neutrophil

function. To prepare these peptides BSA was dissolved in 0.02 M Tris- HCI,
0.I M NaCI, pH 7.8 to a final concentration of 4 mg/ml. Small molecular

weight BSA derived peptides were produced using plasmin and methods
identical to that employed for generation of fibrinogen derived peptides.

Isolation of Polym.orphonuelear Leukoeyte from

Whole Human

Blood

Human PMN were isolated from citrated venous blood of healthy donors
(l ml 3.8% sodium citrate-dihydrate in 0.85% NaCl per 9 ml blood)using

Ficoll-Hypaque gradient centrifugation followed by dextran sedimentation
according to a modified method of Boyum. 20

Briefly, a Ficoll-Hypaque

Solution was prepared by mixing 35.25 ml of Ficoll (9% wt/vol) with 10.00 ml

of Hypaque (50%) and 4.75 ml of distilled

H20.

Then 25 ml of diluted blood

(l part whole blood to l part 0.85% NaCl)was layered over 13 ml Ficoll-

Hypaque solution in a 50 ml polypropylene test tube and centrifuged at 500g
at room temperature for 30 minutes. After centrifugation, the blood cells
were separated into two fractions, an upper layer corresponding to the
mononuclear cell layer at the interface region between the plasma and the

Ficoll-Hypaque solution, and a cell pellet which contained erythrocytes and
granulocytes. After the removal of the mononuclear cell layer, plasma and
the Ficoll-Hypaque Solution, PMN were separated from erythrocytes by

adding 30 mls of 3% Dextran (in 0.85% NaCl), mixing and incubating at room

temperature for 45 minutes. The supernatant which contained the PMN was
removed and centrifuged at 500g for 10 minutes at 4C.

To eliminate the

contaminating red blood cells: The resulting pellet was resuspended with red

26

blood cell lysing solution (0.15 M NH4CI; 0.01M KHCO3; 0.001M EDTA: pH

7.2) followed by 3 washes with HBSS.

The PMNs were adjusted to the

appropriate concentration with HBSS for use in experimental studies. The

PMN preparations contained 82 to 95% neutrophils as determined by
cytocentrifugation and Wright-Giemsa staining. Greater than 98% viability
of isolated cells was obtained as determined by trypan blue dye exclusion.

Determin,ation of Effeet,,of FDFs on.PMN Viability
Preliminary data demonstrated that FDFs inhibited PMN phagocytosis
and killing of bacteria.

However it was not known whether the FDFs or

contaminants in the FDF preparation were toxic to the neutrophils. Trypan
blue dye exclusion is typically used to detemine cellular viability, but it is not

a very sensitive technique. A very sensitive technique for measuring cellular

viability is the measurement of lactate dehydrogenase (LDH). 80 LDH is a

cytosolic enzyme, therefore detection of LDH in the extracellular fluid is an
indication of cell death or loss of membrane integrity. The assay is based on
the spectrophotometric measurement of NADH consumption during the LDH

c.atalyzed reduction of pyruvate to lactate.
Pyruvate + NADH _LD.H,

Lactate + NAD + H+

The protocol for treatment of the PMNs with FDFs was identical to
that used in all functional assays.

FDFs from three different preparations

were used. 0.2 mlofFDFat 30 O D, 15 O D, 7. 5 O D were added to 0 .5 mlof l

x

107

PMN/ml. For the I00% LDH content (positive control) cells were lysed

with 0.1% Triton X. Buffer was added to the negative (sham) controls. The
cells were then incubated in a shaking waterbath for 20 minutes at 37C.
The PMNs were centrifuged down at 400xg for l0 minutes and the

supernatants collected. For the LDH assay 50pl of neutrophil supernatant

substrate was added to 1.0 ml N ADH substrate 0.14 mg/ml.

50

II

of Na

pyruvate (Sigma 490-I) was added to start the reaction, and the absorbance
at 340nm was determined.

Effects of FDF on PMN Morphology
a.

Adherence to Plastic

To determine the effects of FDFs on plastic adherence eutroohils (0.5
ml of

5xl06

PMN/ml) were incubated with 0.2 ml of FDF at 30, 15 and 7.5

OD unit concentrations (for a final concentration of 8.6, 4.3 and 2.15 OD) for
20 minutes at 37C. Following the incubation l set of samples was added to

a 6 well tissue culture plate (Falcon) and incubated for 30 minutes.

An

identical set of samples was washed 2x with 2.5 ml of HBSS followed by

addition to the 6 well plate and incubated for 30 minutes. Photos of the cells
were taken using light microscopy 10x.
b.

Transmiss!on and Scanning Ele.ctron M icroso.py
To determine the effects of FDFs on neutrophil ultrastructure

neutrophils (0.5 ml of

Ixl07

PMN/ml) were incubated with 0.2 ml FDF (final

cpncentration 8.60D) for 20 minutes at 37C shaking in a water bath.
Following the incubation, the cells were placed on ice and submitted in
suspension for scanning and

tra.nsmission electron microscopy.

Effect of FDF on PMN Chemotaxis
The effect of FDF on PMN chemotaxis was determined using a standard

multiwell Boyden chamber assay with 8 lm nitrocellulose filters (Millipore

Bedford MA). For these studies PMN were isolated from peripheral blood as
previously described and adjusted to 5 x

106/ml.

The cells (0.5 ml of 5 x

106

PMN/ml) were added to 0.2 ml of FDF at 30. 15 and 7.5 O.D. unit
concentrations for a final cocentration of 8.6, 4.3 and 2.15 O.D. and

incubated for 20 minutes at 37C shaking in a waterbath. HBSS was added to

control PMN. An aliquot (0.250 ml) of each sample was added to the top

chamber of the plate and 4% activated serum was used as a chemoattractant
and added to the bottom compartment.

triplicate.

CO2

All samples were assayed in

The multiwell plates were incubated for 45 minutes in a moist

chamber followed by staining of the filters. Chemotaxis ,as quantified

using an Olympus microscope coupled to an Optomax image analyzer. Three
high power fields were counted for each fIter resulting in 9 fields for each
sample.

Chemotactic indices were determined, and % inhibition of

chemotaxis expressed as

mean experimental chemotactic index
mean control’ chem0tatic index

1 x 100%

Reversibility of FDF Induced Suppression of PMN Chemotaxis

FDF treated neutrophils and controls were washed to determine if the
effect of FDF on PMN chemotaxis was reversible. FDF treated samples and

c.ontrols were

washed 2x with 2.5 ml of HBSS followed by centrifugaton (500

x g) for 8 minutes. After the second wash, the PMN were brought up to l ml
in 0.5% BSA/HBSS. The cells were then assayed for chemotaxis.

Adherence (Rosetting)
Adherence of an organism to the neutrophil membrane is an essential

step for its subsequent phagocytosis. Adherence is mediated by antibody, the
complement component C3b, and their receptors. The use of opsonized sheep
red blood cells in quantifying binding can provide a means of measuring Fc

receptor function due to the presence of specific anti-sheep red blood cell
antibody on the RBC surface.

Adherence or rosetting of SRBC was

quantified microscopically to assess Fc receptor function on the neutrophil.

For these studies PMNs were isolated from venous blood as described and
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adjusted to 5 x

cells/ml.

FDF aliquots (0.2 ml of O.D. 30, 15, and 7.5)

were added to 0.5 ml of cells and incubated for 20 minutes. The volume was
then brought to l ml by the addition of 0.3 ml HBSS. The l ml samples were
then split into two 0.5 ml samples and 0.5 ml of sheep red blood cells

opsonized with rabbit anti-sheep IgG were added (2.5 x

.

106; PNM/RBC

ratio

l:l) to the PMN. The samples were placed on a rotating tube rack for 30
minutes at 37

After incubation the samples were placed on ice for 15

minutes to arrest phagocytosis followed by centrifugation at 300g for 15
minutes at 4

C.

Extracellular !IBC were not lysed.

At this point the

samples were centrifuged and the resulting pellet washed twice with HBSS.
After the final washing the pellet was resuspended with l ml of HBSS

containing 0.1% BSA.

For each reaction sample duplicate smears were

prepared by using cytocentrifuge (500 r.p.m, for 5 minutes) followed by
Wrights-Giemsa staining. The smears were examined using light microscopy

(l.00x) and the number of adherent red blood cells per PMN in a total of 200
PMN were counted. PMN that appeared to be within the PMN were counted
as adherent.

Erythrophagoeytosis
Binding of a microorganism to a PMN and its subsequent phagocytosis

are the first steps involved in the microbicidal process. Therefore, it might
be a potentially important step where FDF regulates microbicidal activity

e.g., FDF down regulation. The effect of FDF on neutrophil binding and
phagoeytosis was assayed using the erythyrophagocytosis assay.

Many

phagocytosis assays have inherent problems in that they are unable to

3O

differentiate between adherent and ingested particles. Phagocytosis assays

using antibody coated SRBC eliminate this problem because extracellular

RBC can be lysed and eliminated (using

NH4CI lysis)

leaving intracellular

RBCs intact. For these studies PMNs were isolated from venous blood as
described and adjusted to 5 x

106

cells/ml. FDF aliquots (0.2 ml of O.D. 30,

15: and 7.5) were added to 0.5 ml of PMN and incubated for 20 minutes. The
volume was then brought to l ml by the addition of 0.3 ml HBSS. The l ml

samples were then split into two 0.5 ml samples and 0.5 ml of sheep red blood
cells opsonized with rabbit anti-sheep IgG were added (2.5 x

.

I07;

PMN/RBC

ratio l:10) to the PMN. The samples were placed on a rotating tube rack for
30 minutes at 37

After incubation the samples were placed on ice for 15

minutes to arrest phagocytosis followed by centrifugation at 300xg for 15
minutes at 4C. The cell pellet was then resuspended in 2 mls of cold red

blood cell lysing solution (0.5 M NH4CI, 0.01M KHCO3, 0.001 M EDTA, pH
7.2) to eliminate adherent RBC. At this point the samples were centrifuged

at 300g for 15 minutes at 4

C and the resulting pellet washed twice with

HBSS. After the final washing the pellet was resuspended with l ml of HBSS
containing 0.1% BSA.

For each reaction sample duplicate smears were

prepared by using a cytocentrifuge (500 r.p.m, for 5 minutes) followed by
Wrights-Giemsa staining. The smears were examined using light microscopy

(100x) and the number of intracellular red blood cells per PMN in a total of
200 PMN were counted.

Chemilumineseenee ,,Assay.
Adherence of a particle to the neutrophil membrane is associated with
an increase in oxidative metabolism known as the "respiratory burst." This

event is associated with the production of various chemical species important

31

in oxygen dependent microbicidal activity such as hydrogen peroxide,

superoxide anion and singlet
reaction of the

H20 2

oxygen.lO Singlet oxygen

is formed by the

and hypochlorite which involves the action of the

myeloperoxidase-halide system. The formation of singlet oxygen is followed
by the emission of light known as chemiluminescence. Chemiluminescence

was measured to determine the effect of FDF on PMN oxidative metabolism.
Sensitivity was increased by using the cyclic hydrazide luminal .which acts as
a substrate for singlet oxygen. The assay can be performed on resting or
stimulated cells since baseline PMN metabolic activity causes chemilumi-

nescence.

Resting chemiluminescence was performed to determine the

effect of FDF on PMN devoid of any challenge.

For this assay a 5.5 mM stock solution of luminol in DMSO was prepared
and diluted 1.200 prior to use in HBSS.

3.9 ml of HBSS, 0.2 ml of luminol

(final concentration 1.0 lM), 4 ml opsonized zymosan (1.25 mg/ml) were
added to 10 ml scintillation vials and placed in a B counter shifted to l

photomultiplier

tube

(3H

channel).

The vials were dark-adapted for 20

minutes. Prior to the experiment, 0.5 ml of PMN (5 x

104/ml) were incubated

with 0.2 ml of FDF (for a final concentration of 8.6, 4.3, and 2.15 OD units)

for 20 minutes.

The cells were brought to a volume of l ml and

dded

sequentially to the scintillation vials every minute. Values reported are those
for the peak response which routinely occurred after 9 minutes of incubation.

PM N Ho2 Assay
Formation and release of the

H20 2

is dependent upon phagocytosis and

can be used to indirectly quantitate this phenomena.

Stimulated PMNs

produce a respiratory burst in which oxygen is reduced to superoxide which
then dismutates to form

H20 2.
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202 +NADPH202 NADP ++H +
202 + 211 + =-.H202 + O2
H202 produced during

H202 freely

the respiratory burst can be quantitated because

diffuses from the ceil. In the following experiments

H202

was

quantitated using an assay which makes use of a color change that
accompanies the oxidation of phenol red. 56

uses

H20 2

Horseradish peroxidase (HRP)

and phenal red as substrates, and in an excess of HRP, the color

change of phenol red is proportional to the

H20 2 concentration.

PMNs isolated from venous blood were adjusted to a concentration of 2
x

I07

PMNs/ml. FDF aliquots (0.2 ml) at various concentrations 30 OD, 15

OD and 7.5 were added to 0.5 ml cells for a final FDF concentration of 8.6
4.3 and 2.15 respectively.

Buffer was added to controls.

mixture was incubated for 20 minutes in a shaking water bath at 37

final cell volume was brought to 1.0 ml and 10

l of phenol

.

The FDF cell
The

red 20 raM, 10

HRP (14 mg/ml), and various stimuli (10 -6 M. FMLP, 10 -7 M. PMA 10:l

zymosan) were added to the PMNs followed by incubation for l hour on a
rotating tube rack. NaOH (10 pl, 10 N) was added to stop the reaction. The
cells were spun down and the absorbance of the supernatant was determined

at 610 nm.

A standard curve was obtained using 30% H20 2.

concentration of

H20 2

The

for the standard curve was determined using the

molar extinction coefficient for

H20 2

Phagoeytosis Induced Lysozomal

(81 moles/cm -l at 230 nm).

,Enzyme Relea,e

To determine the effect of FDFs on phagocytosis neutrophils were
isolated from peripheral blood and adjusted to 2 x

107 cells/ml. PMN (0.5

ml)

were added to FDF at 30, 15 and 7.50.D. units for a final concentration of

8.6, 4.3 and 2.15 O.D. units and incubated as previously described. Enzyme
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release was stimulated by the addition of 0.3 ml of opsonized zymosan (3.3 x

108/ml) for a final PMN/zymosan concentration of l:10. The cells were
incubated for 45 minutes at 37C on a rotating tube rack followed by

centrifugation (500 g 8 minutes) and removal of the supernatant. 3 different
neutrophil supernatants were analyzed for lactoferrin,

glucuronidase, and

lysozyme content.

Effect of

FDF,on Degranulatio,n.

Degranulation of lysomal granules is an important step in neutrophil
function. These lysomal granules contain a variety of antimicrobial agents

important in the microbiocidal activity of the neutrophil. In addition to their
antimicrobial properties, (e.g. lysozyme, lactoferrin), certain intracellular

granule constituents can act as primary (azurophil) or secondary (specific)
granule markers. 24

The effect of FDF on primary granule release was

determined by quantification of 8 glucuronidase which is a marker for that

granule. Secondary g.anule release was quantified by measuring lactoferrin

(a marker for secondary granules). Lysozyme release was quantified since it
is found in both primary and secondary granules.

Provided below are the

methods used to quantify these enzymes.

B Glucuronidase
The B glucuronidase assay is dependent on the enzymatic conversion of
the chromogenic substrate phenolphthalein glucuronic acid to phenolphthalein

and glucuronate: 24

phenolphthalein glucuronic acid +

glucuronate

H20 B glucuronase phenolphthalein

+

The pH of the sample is changed by the addition of glycine buffer, causing a

shift in color due to the phenolphthalein.

directly proportional to the

The change in absorbance is

glucuronidase concentration.

Neutrophil supernatant (0.1 ml) from the experimental and control
samples was added to 0.7 ml of sodium acetate buffer (pH 4.5) and 0.2 ml of

0.01 M phenolphthalein glucuronic acid (Sigma).

A standard curve was

established using phenolphthalein (Sigma) concentrations fro 2 to 200 lg/ml

(0.7 ml sodium acetate buffer, 0.1 ml standards, 0.2 ml 0.85% NaCI). The
standards and unknowns were allowed to incubate for 18 hours at 37C

followed by the addition of 1.0 ml .4 M glycine buffer (pH 10.5). Absorbance
of unknowns and standards was determined at 540nm.

glucuronidase

concentrations were determined from the standard curve.
Lactoferrin

Assay

Lactoferrin was quantified using an enzyme linked immunoabsorbant

assay. A 96 well microtiter plate was coated with 0.1 ml of 10 pg/ml IgG
rabbit antihuman lactoferrin (Cappel, Malvern, PA) in carbonate buffer pH

9..

The plate was incubated overnight at 4’C followed by washing 3 times

with PBS/tween.

Neutrophil supernatant (0.1 ml) or lactoferrin standard

(Calbiochem, San Diego, CA) 1-64 ng/ml, (dissolved in I% BSA/PBS) was
added to the plate and incubated for 90 minutes at 37C. The plate was
washed 3 times followed by the addition of 0.1 ml of peroxidase conjugated

antilactoferrin (Cappel, Malvern, PA) 1:400 dissolved in I% BSA/PBS. The
plate was incubated for 90 minutes and washed 3 times. 0.1 ml substrate (25
ml citric acid buffer, 25 ml d H20, 5 mg phenylene diamine 0.018 ml 30%

II202) was added at timed intervals. After sufficient color change, the
reaction was stopped with 8N

H2SO 4. Absorbance was

read at 490 nm and
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the lactoferrin concentration of the unknowns determined from the standard

curve.

Lysozyme Assay
Lysozyme hydrolyzes the mucopeptide cell wall structure of the
organism

Microc0ccus lysodeikticus.

This process is accompanied by loss of

absorbance over tine which is proportional to the lysozyme concentration.

A 0.25 mg/ml suspension of Micrococcus lysodeikticus (Sigma, St. Louis,
MO) was prepared using 0.1M phosphate buffer.

0.1 ml of standard or

neutrophil supernatant sample was added to l ml of the

Icrococcu.s

suspension and the loss of O.D. at 450 nm was determined using a
spectrophotometer with kinetics software (Beckman, Brea. CA).

Assay of Microbicidal Activity
Chemotaxis, adherence, the generation of oxygen metabolites, and

degranulation

all

function

to

defend

the

host

against

invading

microorganisms. FDF have been found to affect many of the above functions
and one could hypothesize that FDF might affect killing as well.

vhether FDF affect killing,

To test

the S. aureus killing assay was chosen. This assay

has an advantage in that the compound lysostaphin can be used to lyse

extracellular bacteria if needed.

S. aureus was prepared by overnight culture (18 hours) in trypticase soy
broth, washed and adjusted to 5 x

107/ml

using a standard curve (CFU vs.

A650). FDF (0.2 ml) at various concentrations 30, 15, 7.5 were added to 0.5
ml of neutrophils for a final FDF concentration of 8.6, 4.3 and 2.15,

respectively.

The PMN-FDF mixture was placed in a waterbath for 20

minutes at 37 ’C. After the incubation, 0.5 ml bacteria at 5 x

107 and

5 x

106

were added to the PMN for l:l and 10:l PMN/bacteria ratios, respectively.
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The PMN-bacteria samples were placed on a rotating tube rack and incubated

for I hour at 37C. Following the incubation, 0.2 ml of each sample vas
added to 1.8 ml of

H20

for hypotonic lysis of the neutrophils. Serial dilutions

were carried out and the bacteria were plated out on Muellar-Hinton agar

plates.

The plates were counted and CFU determined following a 24 hour

culture.

Separation of FDF by Molecular Weight Using Ultrafiltration

FDF e30,000 daltons were separated according to molecular weight
using Amicon ultrafiltrations (Lexington Mass). 200 ml of FDF 30,000 MW
were run over an Amicon PM-10 membrane (excludes proteins >I0,000

daltons).

The retentate, (10,000

30,000 daltons) was resuspended to its

original volume with 0.02 M tris buffer and lyophylized.

The filtrate was

them run over a YM-2 and the resulting retentate (100- 10,000 daltons)and

filtrate (1000 daltons) were lyophylized.

H202 assay,

Before incorporation into the

all fractions were normalized according to peptide concentration

using absorbance at 212 nm.

Antibody Blocking of FDF Suppressive Activity
If the inhibitory activity demonstrated in the previous experiments is

fibrinogen related, then if ep!topes are present antibody should be able to
remove all or part of the inhibitory activity.

The following experiments

make use of protein A linked sepharose beads (Sigma) which bind the Fc

portion of IgG thereby forming an insoluble complex.

100 mg of protein A linked

seoharose beads were incubated with

rabbit anti-human fibrinogen serum for l hour.

l ml of

Normal rabbit serum was

used as a control and treated in the same way. Both samples were washed

exhaustively with PBS following the incubation. The sepharose-protein A-IgG
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was centrifuged for 20 minutes at 500 g. The pellets were saved and reacted

with l ml of FDF for l hour. Following the incubation the beads were spun
down and the supernatant (FDF) was saved. These FDF samples were diluted

and used in the

H202 assay using opsonized zymosan as a stimulus.

Protease,,.Sensitivity of., FDF Inhibitory Activity
A nonspecific neutral protease was added to the FDF to determine if
the FDF inhibitory activity is protease sensitive. Protease (2 units Pronase

E, Sigma) from Streptomyc,.e..s griseus made insoluble by covalent attachment
to beads was added to I ml FDF 30 OD for 3 hours at 30C (l unit ,ill
hydrolyze 1.0 mole of N c Benzoyl-L Arganine ethyl ester per minute, pH

7.0, 30 C).

Following the incubation the beads

centrifugation (500 x g 8 minutes).
incorporated into the PMN

were removed by

Protease treated samples were then

H20 2 assay. To

control for nonspecific sticking

of peptides to the beads, and equal volume of Sepharose 4b was added to l ml

FDF removed by centrifugation and the supernatant collected and
incorporated into the

FDF

H20 2 assay.

to inhibit stimulated

The ability of FDF and protease treated

(10-6M f-met-leu-phe) li20 2

production by PMN

was tested.

Effect of FDF on PMN LFA-I and MO-1 Antigen Levels

PMN (0.5 ml,

1.0xl07/ml)

were incubated with buffer o. 0.2 ml FDF for

a final FDF concentration of 8.6, 4.3 and 2.15 as previously described.

Following a 30 minute incubation with the FDF at 37C, the PMN were
placed on ice and brought up to l ml with 0.3 ml of PBS with 0.02% azide for
a final PIN concentration of

5xI06/ml.

0.2 mI of the PMN were added to

0.005 ml mouse anti-human LFA-I (Ortho diagnostics Raritan, NJ)or 0.005
ml of mouse anti-human MO-I (Coulter Immunology Hialeah, FL) and

incubated for 45 minutes on ice. After the incubation period 2.5 ml of PBS

(0.02% azide) were added to each tube and centrifuged 400 g 8 minutes. The

supernatant was decanted and the pellet washed 2 more times with PBS with
azide. After the last wash, 0.005 ml of goat anti-mouse IgG-FITC (Coulter,

Hialeah, FL) was added to each tube and incubated for 30 minutes. The cells

were then washed 3X as above. After the last wash 0.5 ml of 2% buffered
formalin was added to each tube for 30 minutes to fix the cells; followed by

centrifugation. The labelled cells were resuspended in 0.5 ml PBS with azide
and stored in the dark at 4C until analysis.

Analysis was performed at the FACS service (U. Conn. Health Center

Department of Pathology) on a Becton Dickinson FACS analyzer with data
analyzed on a Becton Dickinson consort 30 mini-computer. Cells were grated
on the granulocyte population as observed by viewing volume versus side

scatter.

Stat.istieal Analysis
For each experiment, control cells (buffer treated) were paired with
ex.perimental (FDF treated) c.ells. For this reason, Student’s paired t test was
used to determine whether differences between control and experimental cell

responses were statistically sig.nificant.
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RESULTS

Assessmea.t,.of Fibrinogen purity.
In order to attribute any bioactivity to FDFs, establishing the purity of
The use of pure fibrinogen is of

the fibrinogen used is clearly important.

utmost importance to these studies.

Previous studies in Dr. Kreutzer’s

laboratory had established the commercially available fibrinogen preparations
contain impurities such as complement and fibroneetin which have biologic
activities.

Therefore SDS-PAGE (reduced and non-reduced), as well as

enzyme linked immunoabsorbent assays specific for C3 and C5, were used to
determine fibrinogen purity.

SDS-PAGE Analysis:

The fibrinogen preparation was found to

have no impurities such as albumin detectable by SDS-PAGE (see figure 5).

The fibrinogen sample ran as a single band corresponding to a molecular

weight of 340,000.

SDS-PAGE Analysis Reduced

SamP!.es:

Reduced fibrinogen

samples possessed three bands corresponding to the a,
other contaminating bands were evident.

and

chains.

No

Most importantly, the fibrinogen

preparations were found to be free of fibronectin contamination on SDS-

PAGE. Fibronectin when reduced exhibits a band with a molecular weight of
200,000. Bands of MW 200,000 were not detectable in any fibrinogen samples
run.

Complement

Componen.t Analysis: C3

and C5 antigen levels were

determined using an ELISA. C3 and C5 antigen levels were determined to be
572 ng/mg fibrinogen and 70 ng/mg fibrinogen respectively.

Considerin a

I0% molecular weight conversion of C3 to C3a, or C5 to

57 ng of C3a

and 7 ng of C5a would be present for every

C5a

m of fibrinogen.

This low level
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FIGURE 5
7.5% SDS-PAGE
18 Hour Plasmin Digestion of Fibrinogen

Figure 5: SDS-PAGE pl&smin digestion of fibrinogen

Lane 1: fibrinogen; Lane 2:1 minute plasmin digestion;

Lane 3:15 minutes; Lane 4:1 hour; Lane5:5 hours;

Lane 6:18 hours; Lane 7: molecular weight standards.

of C3 and C5 was found not to have chemotactic activity in our assay and

therefore is unlikely to have significant impact on our in vitro studies.

Pattern of Plasmin Digestion of Fibrinogen
The products generated with the plasmin digestion of fibrinogen are

well known. 18

Generally, the first high molecular weight fibrinogen

fragment to appear is fragment X MW 240,000, followed by fragment Y
145,000, fragment D MW 92,000, and fragment E MW 50,000. The same
pattern of piasmin digestion is seen in figure 5 which is a 7.5% SDS-PAGE gel
of aliquots removed during FDF preparation. At l minute, fragments X, Y,

and D have appeared. At l hour fragment X is beginning to disappear and the
band corresponding to fragment E is starting to appear. At 5 hours fragments

X and Y are gone and there is a dark band corresponding to fragment E. At
18 hours of digestion only evidence of fragments D and E are visualized (see

Figure 5, lane 6).

Therefore. Figure 5 demonstrates that the starting

fibrinogen preparation is pure (within the resolution limits of SDS PAGE) and
that the proteolysis pattern follows a pattern which has been previously
described in the literature. 20

Effect of FDF on PMN Viability

To evaluate the effect of FDF on PMN viability, the LDH assay
chosen.

FDF were added to neutrophil preparations at the biologically

relevant concentrations used in all assays.

For example 0.2 ml of a 30 OD

unit FDF preparation contains 260 lg of protein and corresponds to a starting

fibrinogen concentration of 6 mg/ml.

The assay for LDH measures LDH

leakage from PMN cytoplasm and is designed so that the concentration of

LDH is the rate limiting step.
conversion of

Therefore, the rate of reaction for the

NADH to NAD is directly proportional to the LD.H

43

concentration in the FDF exposed PMN supernatant. 80 As can be seen from
Table l, the background LDH release from control PMNs (b,ffer treated) is
much less than the total amount of LDH present in the cells (Triton-treated

lysed cells). Using 3 different FDF preparations the amount of LDH released
from the PMN treated with FDF is not statistically different from those
treated with buffer.

Therefore, it does not appear that FDF affect PMN

viability or cause cell injury at biologically relevant concentrations when

using LDH-release as a marker of cell viability.

Effect O f FDF on PMN, Morphology
Since FDF had effect on PMN viability experiments were carried out to

investigate the effect on FDF on PMN morphology. A difference between
the morphology of FDF treated cells and buffer treated cells may provide

insights related to effects of FDF on neutrophil function.

Morphological

differences were observed between FDF treated and buffer treated (control)

PMN. When FDF treated PMN were placed on plastic, they appeared round
and failed to spread. Control PMN (buffer treated) were uniformly spread on
the plastic culture dishes (see Figure 6).
When suspensions of FDF treated and control PMN were evaluated using

electron microscopy, control cells appeared to have a granular surface with
short ridges (Figure 7a and 7b).

FDF treated cells appeared less granular

with extended ridges (see Figure 7c and 7d).

The increased length of FDF

treated PMN cellular ridges or processes is confirmed using transmission

electron microscopy. FDF treated PMN (Figure 9) appear to have longer and
more numerous cytoplasmic processes than buffer treated cells (Figure 8).

Interestingly, cytopathologic changes e.g. (vacuolization) are absent from
both FDF and buffer treated cells.
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FIGURE 6
Effect of FDF on Human Neutrophil Adherence to Plastic

To determine the effect of FDF on neutrophil adherence to plastic
0.05 M1 5 X106 PMN/ml were exposed to 0.2 ml of FDF (30 OD) or
buffer (37 C, 20 minutes) followed by incubation on culture
plastic for 30 minutes. Experimental cells appear round and
have not spread (Figure 6B) Control cells have spread (Figure
6A). Magnification 400x.
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FIGURE 6

A. Buffer treated (control) PMN on plastic.

B. FDF treated PMN on plastic.
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FIGURE 7
Scanning Electron )dicroscopy Evaluation of the Effects of FDF on
Human Neutrophil Morphology

To determine the effect of FDF on neutrophil morphology 0.5 ml
of PMN 1 x 107 PMN/ml were exposed to FDF (30 OD) or buffer
(control) for 20 minutes at 37C. Both experimental and control
cells were submitted in suspension for scanning electron
microscopy. Cells were placed on micropore filters (10,000x).
Control and experimental cells have different morphological
appearances. Control cells appear to have granular surfaces with
slight ridges (Figure 7A and 7B). FDF treated cells appear less
granular with extended ridges (Figure 7C and 7D). In a double
blind study using 50 random photo micrographs, 2 independent
investigators were able to distinguish control cells from FDF
treated cells 79% and 72% respectively.
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FIGURE 8
Ultrastructural Analysis of Buffer Treated(Control) Human
PMN by Transmission Electron Microscopy

To control for nonspecific in vitro effects on neutrophil
ultr.astructure human PMN were exposed to buffer (HBSS) for
20 minutes at 37 C. Following this incubation, the cells were
submitted in suspension for evaluation by transmission
electron microscopy (magnification 8000x).
No significant
ultrastructural changes are evident in the photomicrograph.
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FIGURE 9
Ultrastructural Analysis of the Effect of FDF on Human PMN

PMN (0.5 ml of 1 x 107 PMN/ml) were incubated with 0.2 ml
FDF 30 OD (for a final concentration of 8.60D) and incubated
for ’20 minutes. Following the incubation, PMN were
ubmitted for transmission electron microscopy.
When
mpared to control (buffer treated) PMN, no cytopathologic
anges were evident. Additionally, TEM analysis supported
SEM studies (Figure 7) which suggested that surface
-ations are induced by FDF.
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Effect of FDF on Cbemotaxis

Chemotaxis is the directed movement of cells along a chemotactic

gradient and results in the recruitment of cells to a site of inflammation.
The regulation or control of chemotaxis functions to: l) maintain cells at the

site of inflammation, 2) limit tissue injury by limiting cell movement into a

tissue site where healing is occurring.

In this present study FDF were found to inhibit chemotaxis in a dose
dependent manner. As can be seen from Figure 10, inhibition was significant
at the 8.60D units (-52%), 4.3 OD units (-42%) and the 2.15 OD units (-37%)

FDF concentrations. Washing of the cells resulted in removal of almost all of
the inhibitory activity for the 8.6 (-5%) and 4.3 (-3%) doses, and all of the

acivity for the 2.15 FDF dose. Addition of FDF to the upper compartment of
the Boyden chamber resulted in significant inhibition of random migration as

well, for PMN not exposed to chemotactic factors. The chemotactic index

for FDF treated PMN was 696 _+ 113, versus a control chemotactic index of
If21 _+272, p0.05. Additionally, the FDF were not found to be chemotactic

at

the concentrations used, i.e. FDF chemotactic index at a concentration of

8.60D = If21 _+ 133 as compared to a control chemotactic index I061.25

89.61, p>0.05. To control for the non specific effect of small peptides on
neutrophil function, an 18 hour digest of commercially available bovine serum
albumin was prepared.

Due to the presence of significant amounts of

contaninating gamma globulin in the BSA preparation, peptides from this
protein were also produced. Methods used for production of the BSA peptides

were identical to those used for FDF p,oduction.

BSA/gamma albumin

peptides 30,000 daltons (30 OD) were incubated with the PMN for 20
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Figure 10" Effect of FDF on PMaN Chemotaxis.

To determine the effects of FDF on neutrophil chemotaxis,

FDF were incubated with 2.5 x 106 cells/ml, for 20 minutes
at 37 C and incorporated into a standard multiwell Boyden
chamber assay. Buffer treated PMN were used as controls.
Positive wash samples were washed twice following FDF
treatment and were incorporated into the assay. Mean
chemotactic indices were calculated from 4 experiments and
percent inhibition of chemotaxis expressed as (experimental
chemotactic index/control chemotactic index) -1 x 100%.
Significant (p<.05) inhibition of chemotaxis was observed for
2.15, 4.30 and 8.60 dose levels. The FDF inhibition was
significantly reversed by washing of the FDF exposed PMN
prior to addition to the Boyden Chamber Assay.
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minutes followed by incorporation into the chemotaxis assay. The addition of

BSA/gamma globulin peptides to this assay did not result in inhibition of
chemotaxis, but actually caused a small, but statistically insignificant,
increase in chemotaxis. The mean chemotactic index for buffer treated cells

was 1912 + 182 as opposed to a chemotactic index for BSA treated PMN of

2147 +158.

Effect of FDF on SRBC- PMN Adherence
Adherence of a particle, or microbe to the neutrophil membrane often
is receptor mediated and is one of the first steps involved in phagocytosis.
The effect of FDF on antibody coated SRBC-PMN adherence was measured

to probe for possible effects of FDF on membrane receptors.
Figure II shows the immune adherence index plotted versus FDF
concentration.

As can be seen from the graph, FDF significantly decreased

the adherence of antibody coated sheep RBC to human PMN. A significant

dose response was not seen in this assay.

This may be due to the large

standard error and the choice of index. To rule out any effect the FDF may
have on the RBC, FDF (30 O D) were added to the SRBC followed by washing.

Addition of FDF to the RBC had no effect on PMN-RBC adherence when

compared to non FDF treated PMN-RBC reactions (data not shown).

ffect of,, FDF on, PMN Phagoeytosis
Phagocytosis is an important function involved with PMN microbicidal
activity and wound healing.

Any effect of FDF on phagocytosis would be

important in regulating a variety of responses that occur as a result of this
function, e.g. cell activation, degran,Hation.
When the FDF were added to the PMN samples, phagocytosis was

significantly inhibited (Figure I2). Inhibition is significant and increased up
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Figure 11"

Effect

of FDF on PMN-SRBC Adherence.

To determine the effects of FDF on PMN-SRBC
adherence, FDF were incubated with a final
concentration of 2.5 x 106 PMN/ml. for 20 minutes
at 37C. Antibody coated sheep red blood cells
were added to the PMN (PMN:RBC 1"1) and
adherence was quantified microscopically.

Adherence Index
Number of PMN >1 adherent
’RBC/200 PMN. Sample duplicate smears were
prepared and 3 fields per slide counted. Values
represent the means of 3 experiments. Significant
inhibition of SRBC adherence was observed for the
2.15, 4.30 and 8.60 dose levels (p<.05).
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Figure 12" Effect of FDF on Phagocytosis of
Opsonized RBC by PMN.

To determine the effect of FDF on PMN
phagocytosis, various concentrations of FDF were
incubated with the PMNs for a final concentration
of 2.5 x 10 (i PMN as previously described.
Opsonized RBC were added to the PMN at a 1"10
PMN:RBC ratio followed by lysis of adherent
extracellular RBC by ammonium chloride. PMN
were cytocentrifuged and sample duplicate smears
prepared. Phagocytosis was quantified
microscopically counting 3 fields of 200 PMN.
Number of PMN >_.1 intracellular
Phagocytic index
RBC/200 PMN. Values represent the means of 4
experiments. FDF significantly inhibited
phagocytosis at all FDF doses(p<.05).
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to the FDF concentration of 4.3, resulting in approximately 50% inhibition of

phagocytosis.

At the 8.6 FDF concentration there is a slight increase in

phagocytosis, however, it is still significantly less than the control samples.

As with the adherence assay, FDF (30 OD) were added to the RBC first,
followed by washing to rule out any direct effect of FDF on the RBC. There
was no difference between RBC treated with FDF followed by washing, and
controls in the phagocytosis assay.

Effect of FDF on PMN Chemiluminescence

PMN chemilumescence is an excellent indicator of PMN oxidative
metabolism and has been be used as a general indicator of cell activation. 78

To determine the effect of FDF on cell activation and PMN oxidative
metabolism, PMN resting and stimulated chemiluminescence was measured.
Resting

Chemiluminescence

is

concentrations of FDF used (Table 2).

significantly

inhibited

for

all

FDF does not activate PMN and

appears to be suppressing the oxidative metabolism of the resting ceil.
Stimulated Chemiluminescence was inhibited for all doses tested (Table

2). Statistical significance was achieved at the 8.6 and 2.15 FDF dose level.

Effect of FDF on PMN H20__2 Production

Stan.dar.d Curve for. H202production
Previous reports by Pick et a156

have shown that the change in

absorbance that accompanies the oxidation of phenol-red is linear and an

accurate indication of
determine

H20 2

H20 2

concentrations from 0-80 pM of

H20 2. To

concentrations in our assay, and test the direct effect of

FDF on our assay system, a standard curve for H202 levels was established.
The standard curve (Figure 13) demonstrates that a relatively linear

relationship .can be obtained between absorbance at 610 nM and

H202
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TABLE 2
EFFECT OF FDF ON RESTING AND STIMULATED HUMAN PMN CHEMILUMINESCENCE

1

PERCENT INHIBITION

FDF

CONCENTRATION

8.6 absorbance

RESTING PMN

unit

4.3 abosrbance units

2. 15 absorbance units

1.

percent inhibition

sTIMUC’TED

-35.25+2.45
p<.05

-31.85+/-3.84

-38.25+_1.94

-28.6+/-6.08

p<.05

p>.05

-28.5+_4.8

p<.05

.20.83-1-4.78
p<.05

n=4

n=6

p<.05

(Experimental CPM/Control CPM) -1 x 100%.

2. PMN stimulated with opsonized zymosan.
3.

PMN 2

FDF concentration expressed as absorbance units at 212 nm.
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H202 Standard Curve Using Phenol Red

Assay.

H202 concentration was determined by usin,,e,
H202 nolar extinction coefficient of 81 moles/cn.
at 230 nm.

A linear dose response (Abs. vs. H202)

was seen between 0 and 50 micromoles/ml.
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concentration. FDFs were added to the standard curve samples and they did

not interfere with the assay.

St!mu,!a,,ted P,./IN. H202
H202
activity.

Production

is an important chemical species involved in PMN microbicidal

It is required for the functioning of the myeloperoxidase-halide

system which is thought to be of primary importance in PMN microbicidal
activity. For this reason the effect of FDF on PMN

H202

production was

tested.
Figure 14 shows the ability of FDF to affect
different stimuli. FDF significantly inhibit
fashion for all three stimuli.

H202

H202

release by 3

release in a dose dependent

FMLP stimulated

H202

production is more

susceptible to low concentrations of FDF than PMA or zymosan. This effect

may be due to the strength of the stimulus involved. Interestingly, FDFs
inhibit

H202

release by FMLP and PMA. These stimuli are not dependent on

Fc receptor function or phagocytosis, but are dependent upon cytoskeletal
organization.

Incubation of PMN with peptides derived from an 18 hour

plasmin digestion of BSA/gamma globulin failed to inhibit

by PMN.

H202

release from buffer treated cells was 52

H202

production

m/ml as opposed

to 57 pm/ml for BSA treated PMN.

Effect of FDF on Degranulation
Degranulation is dependent upon stimulus-response coupling at the PMN
membrane.

Therefore the effect of FDF

degranulation was studied.

on

zymosan stimulated

Certain granule constituents may be used as

markers: lactoferrin is a secondary granule marker, and 8 glucuroni.dase is a

primary granule marker.

secondary granules.

However, lysozyme is found in both primary and
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Figure 14" The Effect of FDF on Stimulated
Release by PMN.

H202

The ability of FDF to affect H202 release
by 3 different stimuli (10-6M FMLP, 10-7M
PMA and 10’1 opsonizecl zymosan) was
assayed using the phenol red assay for H202.
Values represent the means of 5
experiments. FDF were incubated with a
final PMN concentration of 1 x 107 PMN/ml.
Significant inhibition of H202 release was
seen for all 3 stimuli except for PMA and
zyymosan at the 2.30 dose level.

FDFs significantly inhibited lactoferrin release from PMN at the 8.6
and 2.15 dose levels (Fgure 15). The values represent the means for three

independent experiments. Inhibition of lactoferrin release occurred at the
4.3 dose level, however, it was not statistically significant. FDF statistically
increased 3 glucuronidase release for all three dose levels (Figure 16).

Interestingly, FDF had no statistically significant effect on lysozyme release
(Figure 17).

Effect of FDF

on,PMN Micr,obicidal A,,e, tivity

Adherence, phagocytosis, cell activation and

H20 2

production are all

important functions involved in PMN microbicidal activity. 37 Therefore one
would predict that the FDF that affect these functions would affect PMN

microbicidal activity as well.

Thus the ability of FDF to inhibit PMN

microbicidal activity was investigated.

Figures 18 and 19 show that FDFs significantly inhibit PMN killing of S.

aureus at both I:l and 10:i PMN/Bacteria ratios. As reflected by an increase
in S.

aur.eus viability,

statistical significance was achieved at the 8.6 FDF

concentration for the 10:i PMN/Bacteria samples (figure 18).

It would

appear that at lower dilutions, inhibition can be partially overcome if the
PMN greatly outnumber the bacteria present.

At the l:l PMN/Bacteria

ratios (figure 19) significance is achieved at the 8.6 and 4.3 concentrations,
but not at the lowest dilution.

This is in keeping with the dose response

relationships seen for the peptides; at lower dilutions the inhibitory effect is

of smaller magnitude and statistical significance is lost.

Antibody Blocking of FDF Suppressive Aqtivity
To verify the fibrinogen derived nature, of the FDF activity, antibody
blocking studies were undertaken.

Ths, the removal of FDF inhibitory
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Figure 15" The Effect of FDF on Lactoferrin Release
from Human PMN Granules.

To determine the effect of FDF on secondary
granule release, lactoferrin (a secondary granule
marker) was quantified in phagocytic supernatants
from control(buffer) and FDF treated PMNs. For
these studies, various concentrations of FDF were
incubated with 1 x 107 PMN as previously
described followed by stimulation with opsonized
zymosan (10"1 zymosan’PMN). Buffer treated
(HBSS) samples served as controls. Lactoferrin
release was quantified by ELISA using a monoclonal
Ab. FDF significantly inhibited phagocytosis
stimulated lactoferrin release by PMN at the 8.60
and 2.15 dose levels. Lactoferrin release at the
4.30 dose level was inhibited, however statistical
significance was not achieved.
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Figure 16" The Effect of FDF on Glucuronidase
Release from Human PMN

To determine the effect of FDF on primary
granule release, g glucuronidase (a marker for
primary granules) was quantified. FDF were
incubated with 1 x 10 7 PMN/ml.. as previously
described in the methods section. 13 glucuronidase
release was stimulated with opsonized zymosan
(10"1 zymosan’PMN). Supernatants from 3
different neutrophil samples were analyzed for
glucuronidase release. Values represent the means
of 3 experiments. FDF significantly increased
enzyme release at all dose levels (p<.05).
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Figure 17" The Effect of FDF on Lysozyme Release
from Human PMN Granules
The effect of FDF on phagocytosis induced
release of lysozyme, a marker of primary and
secondary granules, was determined using the
general protocol outlined in the methods section.
FDF were incubated with a final concentration of 1 x
10 7 PMN and lysozyme release was stimulated with
opsonized zymosan 10"1. Lysozyme release was
quantified from 3 different PMN supernatants by
measuring the lysis of Micrococcus lysodeikticus.
FDF had no significant effect on lysozyme release

(p>.05).
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Figure 18" Effect of FDF on Killing of
PMN .at a 10"1 PMN" Bacteria ratio.

S.aureus by

To determine the effect of FDF on PNEN
nicrobicidal activity, FDF were incubated with PMN
at 5 x 107 PMN/ml for 20 minutes. Following this
incubation 5 x 106 S....aure.us were added to the PMN
to a final 10"1 PMN’Bacteria ratio and incubated.
The PMN .S, aureus mixture was subjected to

hypotonic lysis and plated on Meullar-Hinton agar.
S. aureu.s viability is expressed as CFU x 104
surviving per sample. Values equal the means of 6
experiments. FDF significantly inhibited PMN
killing of S... aur.eus at the 8.60 dose level (p<.05).
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Figure 19" Effect of FDF on Killing of .S. aureus by
PMN at a 1"1 PMN’Bacteria ratio.

To determine the effect of FDF on PMN
microbicidal activity, FDF were incubated with a
final PMN concentration of 5 x 107 PMN/ml as
previously described. Following the incubation 5 x
10 7 S. aureus bacteria were added to the PMN to a
final PMN/Bacteria ratio of 1:1. PMN were
subjected to hypotonic lysis followed by plating on
Muellar-Hinton agar. .S..aureu.s viability is
expressed as CFU surviving per sample. The data
presented represents the means of 7 independent
experiments. FDF significantly suppressed PMN
killing of S. aureus at the 4.30 and 8.60 dose levels
(p<.05).

activity by fibrinogen specif}c antibody would lend support to the claim that
the inhibitory activity seen is fibrinogen derived.

In a series of 3 experiments, antibody absorbed or NIS treated FDF
were added to PMN in the

H202 assay using opsonized zymosan as a stimulus.

As can be seen in Figure 20, cells exposed to the antibody absorbed samples
released significantly more

H202 at

the 8.6 and 4.3 dose levels.

Controls

demonstrated that resting cells were not activated by the Ab absorbed FDFs,
thus they contained no inherent stimulatory activity (data not shown).

.ny

effect of antibody or serum contamination can be ruled out in that the
normal rabbit serum absorbed FDF samples are not different from those

exposed to FDF alone.

Separation of

FDF. Activity by M.olec .ul.ar Weight

To develop a preliminary characterization of FDFs responsible for
suppression of PMN production, FDF were separated according to molecular

weight using Amicon ultrafiltration (see Figure 21). Two distinct molecular
weight ranges of activity were seen. FDFI000 daltons and 10,000- 30,000

significantly suppressed PMN

production.

No significant

activity was seen for the 1,000-10,000 dalton fraction.

Thus these data

d.altons

H20 2

suggest a heterogeneous distribution of at least l FDF activity i.e. PMN

H20 2 suppression.

E.ffeet of .Pronase-E.on FDF Inhibit0.A..etivity
To determine whether FDF activity was protease sensitive, a broad
spectrum protease was used (see table 3 for peptide bond susceptibility).

Figure 22 represents the effect of the neutral proteaseo Pronase E, on FDF
inhibitory activity. Non protease treated FDF significantly inhibited FMLP
stimulated

H20 2

production by PMN.

However, there was no significant
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Figure 20" Effect of Anti-Fibrinogen Antibody on

FDF Inhibitory Activity
The ability of specific antibody to remove FDF
activity was tested using anti-fibrinogen antibody.
Rabbit anti-human fibrinogen antibody was
incubated with protein-A-sepharose for 1 hour.
(Normal rabbit serum was used as a control.) The
sepharose protein-A-anti-fibrinogen was added to
FDF followed by centrifugation and removal of
antibody. FDF, anti-fibrinogen treated FDF, and NRS
treated FDF, were tested for their ability to inhibit
PMN H202 production in the phenol red H202 assay.
Anti-fibrinogen antibody significantly removed FDF
inhibitory activity at the 4.30 and 8.60 dose levels.
There was no significant difference between FDF
and NRS treated FDF in their inhibition of PMN I-t202
production.
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Figure 21" Fractionation of FDF Inhibitory (H202
production) by Ultrafiltration.

To further characterize FDF inhibitory activity FDF
< 30,000 daltons were separated into 3 molecular
weight fractions using amicon ultrafiltration. Each
fraction was normalized with respect to protein
concentration and assay for inhibitory effect on
PMN H202 production. Values represent the means
of 4 experiments Two distinct molecular weight
ranges of activity were found: <1,000 and 10,00030,000 daltons. The fraction 1,000-10,000 daltons
had no significant activity which rules out any nonspecific effects of small fibrinogen peptides on PMN.
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Figure 22" Effect of Pronase-E on the
Inhibitory Activity of FDF.

PMN-H202

The protease sensitivity of FDF inhibitory
activity for PMN production of H202 was tested
using a non-specific protease from Strept0myces
gris.eus covalently linked to sepharose beads. FDF
were incubated with 2 units of bead immobilized
pronase-E, or control beads for 3 hours. The
protease immobilized or control beads were
removed from the sample by centrifugation. The
resulting supernatants were tested for PMN
inhibitory activity using the phenol red H202 assay.
Values represent the means of 3 experiments.
There were no significant differences between
protease treated FDF and control samples (beads
alone) in their ability to inhibit H202 production by

PMN.

difference between the samples treated with protease linked to beads, and
those treated with beads alone p>0.05 in their ability to inhibit
production.

H20 2

There were differences between the protease control samples,

protease samples, and the FDF treated samples in their inhibition of

H20 2

production at the 2.15 and 8.6 dose levels. These differences are not believed

to be due to protease activity, since there are no differences between the

samples treated with protease linked to beads and beads alone, but due to non

specific absorption of FDF to the beads thus non-specifically removing FDF

activity.

Effect of,FDF ,on LFA- ! and

M..O-I An.tigen Levels_ on PMN

Data developed by this project suggested the possibility that part of the

FDF activity may involve adhesion molecules. Thus, the effect of FDF on
two adhesion molecules on the surface of human PMN was evaluated, i.e.

LFA-I and MO-I. As can be seen from Figure 23, FDF significantly increase
the amount LFA-I antigen on the surface of PMN at the 2.15 dose level

(p<0.05). Doses 4.3 and 8.6 increased the level, however, the increase was
not statistically significant. Interestingly, FDF had no significant effect on
"r/Io-I antigen levels

(Figure 24). Thus these data raise the possibility that

the FDF induced alterations of adhesion molecules on the surface of the PMN

may be responible for the suppressive activity of the F DF on human
neutrophils.
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Figure 23" Effect of FDF on MN LFA-] Antigen
Expression.
The ability of FDF to alter adhesion molecule
expression on the surface of PMN was studied using,
a monoclonal Ab. to LFA-1. 5 xl06 PMN/ml were
incubated with FDF for 20 minutes and then placed
on ice. PMN were labelled with mouse anti-human
LFA-1 followed by washing and labelling with a
secondary antibody conjugated to FITC. Cells were
fixed and submitted for FACS analysis. Values
represent the average of mean fluorescent values
for 4 experiments. FDF significantly increased the
mean fluorescence(and LFA-1 antigen levels) on
PMN at the 2.15 FDF dose level (p<.05).
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Figure 24" Effect of FDF on PMN MO-1 Antigen

The ability of FDF to affect cell adhesion
molecules on the surface of PMN was studied usino
a monoclonal antibody to MO-1. 5 x 106 PMN/ml
were incubated with FDF for 20 minutes and then
placed on ice. PMN were labelled with mouse antihuman MOol followed by washing and labelling
with a secondary antibody conjugated to FITC. Cells
were fixed and submitted for FACS analysis. Values
represent the mean fluorescent values for 3
experiments. FDF had no significant effect on MO-1
antigen levels.

DISCUSSION
Fibrin is found in many inflammatory disease processes and is known to
be rapidly metabolized by a variety of enzymes, including plasmin, which

produce a wide range of degradation products locally at the site of

inflammation.

These degradation products have been shown to possess a

variety of effects in vitro_ and in vivo.

coagulation,5

vasopermeability,22

FDFs have been shown to affect
endothelial

integrity,64,65

cell

inflammatory cell chemotaxis, 21 angiogenesis, 33 lymphocyte function 20 and
delayed-type hypersensitivity reactions61 in vivo.

However, to date, no

systematic studies have been undertaken to investigate the effect of FDFs on
neutrophil function in vitro or in vivo. This is surprising in light of the fact
that: l) neutrophils are present in virtually all lesions in which fibrin(ogen) is

found, 2) the neutrophil is thought to be an important component of host
defense.

In its role in host defense, the neutrophil is a highly specialized cell
with its primary function being the destruction of microorganisms and the

preparation of tissue for healing. 38

The neutrophil response to microbial

invasion can be divided into a number of stages including

l)

A.dherence

to

vascular endothelium followed by chemotaxis which recruits nflammatory
cells to the site of microbial invasion.

microorganism

binds

to

the

2) Binding and Phagocytosis:

neutrophil

membrane

which

the

invagnates

internalizing the microorganism in a phagocytic vacuole, 3 Killing of the
Microorganism: which is accompanied by a metabolic burst in which reactive

oxygen metabolites are produced, fusing of enzyme containing granules with
the phagolysosome, and release of granule components extracellularly. ..hus

factors which would modulate any or all of these events i.n host defense could
have a marked impact on microbial invas,on and tissue injury.

This thesis is the result of my preliminary studies (see Appendix

experiments l and 2) which demonstrated the ability of FDF to inhibit PMN
microbicidal activity The results of the present studies have not only

supported the ability of FDF to suppress microbicidal activity i_.n vitro., but
have demonstrated the ability of FDF to inhibit a number of neutrophil
functions important in host defense (see Table 4).

Since many of the

functions studied are adhesion dependent, the observed FDF inhibitions of

neutrophil function may involve alterations in neutrophil adherence.
Recently investigators have begun to recognize the importance of adhesion
molecules on the surface of the PMN. I

It has been hypothesized that cell

surface adhesion molecules represent a group of surface receptors such as the
fibronectin receptor,

platelet fibrinogen receptor, leukocyte adhesion

molecules (LFA-I, MO-l), thought to

belong to a family of wide ranging

molecules linked with the cytoskeleton 34. In this capacity they function in
33 wound
wide ranging control of cell functions such as migration in embryos,

healing,33 phagocytosis 34

and T lymphocyte help 34 to name

lust

a few.

Small molecular weight peptides produced by enzymatic activity (FDFs) may
bind to these cell surface molecules inhibiting cell movement during

embryogenesis and chemotaxis, thus providing fine tuned local regulation of
these processes.

How would FDFs function in inflammation and what role do bacteria
play in this process?

My working hypothesis is that low molecular weight

FDFs produced late in an inflammatory lesion function to down regulate
(inhibit) the immune response limiting local tissue damage.

However,

bacterial proteases may take advantage of this process, producing FDF which
allow for increased bacterial growth and tissue damage.

Therefore, FDFs
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may play a role in many disease processes where bacteria are present and
local regulation of disease activity is occurring (e.g.

inflammatory

periodontal disease).

In order to study the effect of FDF on host defense, the effect of FDF
on each stage involved in P MN function was examined. As mentioned earlier
these steps include adherence, chemotaxis, phagocytosis, degranulation and

oxygen metabolism. In the present studies, FDF were found to inhibit all of
these steps as well as produce recognizable morphologic changes and up

regulate cell surface adhesive molecules (see Table IV). Provided below is a
detailed discussion related

to

those

experimental findings and their

implications for the regulation of neutrophil function

!n

vitro and host

defense in vivo.
Fibrinogen Purity

and. the.....Use of..Biologically Relevant Concentrations

Previous studies which have investigated the effects of FDF on

lymphocyte function have not addressed the question of fibrinogen purity

prior to enzymatic digestion. Fibrinogen preparations may contain impurities
capable of stimulating (e.g. complement) or inhibiting (e.g. fibronectin) cell

function. In this study considerable effort was made to purify the fibrinogen
prior to digestion. Complement contamination was sufficiently low so that it
was unlikely to be of biological significance in these reactions. 43

Since

fibronectin was not evident on SDS PAGE, it appears that the starting protein
was highly purified fibrinogen.
The concentration of fibrinogen or FDF used in in vitro experiments

must be consistent with that found in vivo for the experiments to have
biologic relevance. The highest concentration of peptides used in the various
experiments presented (30 absorbance units) corresponded to a starting
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TABLE 4
SUMMARY OF EFFECT OF FDF ON NEUTROPHIL FUNCTIONS
FUNCTION

VIABILITY
CHEMOTAXIS

PHAGOCYTOSIS
CHEMILUMXNESCENCE

H202 RELEASE
LACTOFERRIN RELEASE
13 GLUCURONIDASE RELEASE

LYSOZYME REI EASE
MICROBICIDAL ACTIVITY

MO- 1 ANTIGEN
LFA-1 ANTIGEN

EFFECT

fibrinogen concentration of 6 mg/ml. Fibrinogen is present in plasma at a

concentration of 3-4

reactant, can reach

mg/ml.19 Moreover, fibrinogen, as an acute phase
concentrations as high as 30-40 mg/mll9 during acute

inflammation. The deposition of large amounts of fibrin in both acute and
chronic inflammatory lesions may lead to even higher

local concentrations of

FDF. Therefore the concentration of FDF used in the experiments described
is within the range seen in

.viv 9 and

in fact much higher levels may be seen in

Effect of FDF on Chemotaxis

One of the first steps in the inflammatory process is the movement of

P MN from the vascular bed to a site of injury or bacterial invasion. Once the
cells arrive at the site of inflammation, mechanisms must exist to limit their

further movement out of the area.

Moreover, mechanisms must exist to

reduce or prevent chemotaxis of additional cells into a lesion once healing
has been initiated, preventing further tissue damage by PMN proteases.

FDFs may play a role in these immunoregulatory pathways.
Experiments presented in this thesis have shown that FDFs can inhibit

PMN chemotaxis as well as random migration. This inhibition was found to
be reversible upon washing, and specific since peptides derived from BSA

degradation had no effect on chemotaxis. The finding that the inhibitory

effects

of

FDF

are

reversible

supports

their

role

as

possible

immunoregulators. Permanent down regulation of PMN by a factor (FDF) in
an inflammatory lesion may not be desirable.

Present experiments have not found these small peptides (FDF) to be
chemotactic.

It must be noted, however, that other studies have found

fibrinogen peptides to be chemotactic.

IIoweve’, these studies employed

either thrombin derived peptides 36, or found major chemotactic activity of

molecular weight >_.30,000

daltons.47

In addition, no study to date has

investigated the effect that preincubation of PMN with FDF have on PMN

chemotaxis as this study has done.

In support of experimental findings related to chemotaxis presented

here, recent experiments by other investigators in our laboratory have
demonstrated the ability of FDF peptides, identical to that used in these

experiments, to inhibit endothelial cell migration.33

Therefore, there is

evidence that FDFs affect chemotaxis of other cell types as well.

In light of these data it is hypothesized that that FDFs may bind to the
neutrophil membrane mimicking matrix proteins such as fibronectin and

fibrinogen. The FDFs may function to saturate membrane bound adhesive
molecules reducing cell adhesiveness and motility.

Effect of FDF on

SRB.CT.P..MN...Ad.h.erence and...P.hagocytosis

The first step in phagocytosis is the binding of a particle to the

neutrophil membrane and FDFs were found in this study to significantly
inhibit binding of antibody coated SRBC to P.N membranes. A clear dose

response was not seen in the adherence assay. However, this may be due to
the high standard error present and the selection of the index used for

measurement of adherence. Counting all cells with l adherent RBC tended
to obscure the finding that with increasing FDF concentration there were less
cells with 2 or 3 adherent RBC (see Appendix).

Inhibition of binding can

affect all subsequent steps in killing and it cannot be said whether the
inhibition of phagocytosis seen is due to a direct effect on phagocytosis or
due to decreased binding, floweret, inhibition of phagocytosis was significant

at all dose levels in the erythrophagocytosis assay.

31

A possible mechanism to explain the effects of FDF on SRBC adherence
and phagocytosis might include binding of FDF to the Fc receptor and other

cell surface adhesion receptors. For example, nhibition of platelet receptor

binding to fibrinogen by small peptides has been described58 and this receptor
has been found on P MNs. 8

It is possible that FDF bind the Fc receptor of

PMN down regulating adherence and subsequent phagocytosis of antibody
coated cells.

Any effect of the FDF on the RBC is less likely due to

experiments that incubated the FDF with the RBC followed by washing and

incorporation into the assay. FDF treated RBC had no effect on adherence

or phagocytosis. Thus these studies suggest that FDF inhibition of SRBC-

PMN adherence and phagocytosis is due to a direct effect on the PMN.
Effect of FDF o n Chemiluminescence and H20__2

Production

It is well established that binding of an opsonized particle or a
chemotactic peptide to a PMI’I results in a metabolic burst in which light
(chemiluminescence) and several reactive oxygen metabolites

(tt202)

produced. 78 Because of the role of these oxygen metabolites in host defense
the effect of FDF on

II20 2 and chemiluminescence was studied.

It is noteworthy that FDF had effects on the resting cell, inhibiting
resting chemiluminescence.

This

s

an effect, that is independent of the

binding of a chemotactic factor or opsonized particle to the cell. It appears
the resting cell is down regulated by FDF.

FDFs have been shown to inhibit IgG mediated RBC adherence and
phagocytosis to the PYIN membrane. Addition of the FDF to the SRBC had
no effect. Therefore, evidence exists for FDF affecting binding of opsonized

particles to the P},N membrane. This fact may, in part, explain the effect of

FDF on stimulated chemiluminescence. Part of the effect seen may be due

to the inhibition of binding of opsonized zymosan by the FDF resulting in

decreased stimuli. }{owever, the suppressive ei’fects of FDF may be a result

of other effects on PMN metabolism as suggested from the resting
chemiluminescence data.

Chemiluminescence is an excellent indicator of PMN oxidati.ve
metabolism. 78 Therefore the finding that FDF inhibit both stimulated

chemiluminescence and

H20 2

production is not surprising. The finding that

FDF inhibit H20 2 production from 3 seemingly unrelated stimuli supported
the general suppressive effect of the FDF. The general suppressive effect on

H20 2 production

may be due to FDF affecting a common cellular pathway, or

due to a number of peptides affecting individual pathways. Another possible

mechanism to account for these data might include FDF binding to cell

surface receptors.

This binding could prevent the interaction of serum

opsonins (e.g. C3b on zymosan) and chemotactic factors with their individual

receptors; inhibiting the stimuls for .H202 production. The peptide sequence

x-Arg-GIy-Asp-y, found to inhibit cell adhesion to fibrinogen and

fi.bronectin, 16 is found in the fibrinogen molecule and the complement
component

C3.16

Moreover, it has been found to bind to a number of cell

surface receptors. 34 It is possible that FDF with sequences related to x-Arg-

Gly-Asp-y, or other peptides bind to the C3b or f-met-leu-phe receptor
inhibiting binding and

H202 production. Some degree of specificity

was

demostrated in present experiments when peptides derived from BSA were
shown not to inhibit

activation is

[note

H202

production.

The effect of FDF with PMA

complex since PMA is thought to have multiple effects in

addition to activating protein kinase

.52

Protein kinase C is involved with

the phosphorylation of proteins resulting in the control of calcium fluxes and
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receptor transport.

PMA, in its activation of protein kinase C, has been

thought to be an agonist. 52 However, protein kinase C can be involved with
7eceptor down regulation and a report describes the PMA inhibition of

neutrophil response to chemotactic peptides. 50

FDF by binding to the

neutrophil membrane may act to affect PMA transport into the cell or may
function to decouple the activation of protein kinase C from cell activation.

Ef.f.ect 0f FDF on PMN .Degranulation
A critical aspect of the phagocytic process is the incorporation of

agents toxic to microorganisms into the phagocytic vacuole.

Following

binding and phagocytosis, PMN cytoplasmic granules (separated into two
distinctive populations, primary and secondary) move and fuse with the

phagocytic vacuole releasing various proteolytic enzymes.

Moreover, the

contents of the granules can often be released extracellularly due to
incomplete closure of the phagocytic vacuole, or ruture of the cell causing
death of extracellular microorganisms or host tissue damage. The control of

PMN degranulation is not well understood, however, different granule
populations (primary and secondary) are believed to be responsive to

independent stimuli and secondary granules are involved in receptor transport

to the cell surface (e.g. FMLP). Secondary granule release can be elicited
with stimuli such as PMA and Con A while primary granule release cannot 76.
Release of primary granules requires a greater stimulus than secondary

granules 76. In addition, secondary granules are thought to be more readily
released into the extracellular environment; primary granules tend to fuse
with the phagolysosom e 76.
Since prilnary and secondary granules may require different stinuli for

release, it is not surprising that FDF have the opposite effects on their

release.

FDF suppress secondary granule release and potentiate primary

granule release. The effect of F DF on neutrophil granule release may affect
the character of PMN mediated connective tissue destruction. For example,

an increase in primary granule release would cause an increase in the release

of enzymes such as

elastase

which

can degrade connective tissue

proteoglycans 24. Inhibition of secondary granule release could function to

prevent the release of an important anti-microbial agent (lactoferrin)as well
as inhibit the transfer of f-met-leu-phe receptors to the cell surface.
Whether FDF affect signal response coupling, cytoskeletal events or some

other cellular process has not been elucidated.

However, the effect of

peptides found in inflammatory lesions could alter the course and outcome of
disease processes in vivo.

Effect

of. FD.F on PMN Mic..robicidal Activity

The primary function of phagocytosis degranulation and the generation

of oxygen metabolites is to defend the host against invading microorganisms.

Since FDF have been shown in this thesis to inhibit many of the functions
involved in PMN microbicidal activity, it is not surprising that microbicidal

activity was suppressed. Present studies demonstrated that FDF inhibition of

killing was dose dependent, statistically significant, and became more
pronounced with the l:i PMN/Bacteria ratio. PMN to bacteria ratios of l:l
and 10:I were chosen because at these ratios PMN killing has been shown to
be the most efficient. 38 Experimental conditions in which bacteria greatly

outnumber PMN (e.g. bacterial plaque in the gingival sulcus) might introduce
other variables such as bacterial toxins etc. which might cause neutrophil

death.

Effect of FDF on LFA-I and MO-I Antigen Levels

Many of the functions that FDF have been shown to affect are
dependent on adhesion of microorganisms to the cell surface. In keeping with
the hypothesis that FDF affect cell surface adhesion molecules, experiments

were performed to examine the effect of FDF on the cell adhesion molecules

LFA-I and M O-I.

Evidence is accumulating that these molecules are

important in neutrophil function and host defense I.

Present experiments

have demonstrated the ability of FDF to significantly increase the amount of

LFA-I antigen on the surface of PMN. FDF had no significant effect on MOl antigen levels. The greatest effect on LFA-I antigen levels occurred at the
lowest FDF concentration. These data suggest that FDF may be binding to

cell surface adhesion receptors stimulating an increase in cell surface

receptors in a manner analogous to the binding of a chemotactic factor such
as f-met-leu-phe. For example, when a PMN binds to a venuole in vivo, up
regulation of adhesive receptors may occur.

However, if FDF are present

(the inflammatory lesion is resolving), FDF binding to adhesive receptors
might block margination and diapedesis.
I_dentity of Active FDFs
The identity and relative homogeneity of FDF(s) which down regulate
neutrophil function has not been demonstrated. In fact, it is clear that the

FDF preparations contain a variety of peptides. Thus some peptides may be
stimulatory and others may be inhibitory. Clearly, in vitro and in vivo, the
relative concentration for the PMN of each of the peptides vould determine
the ultimate regulation of PMN function.

Data obtained from separation of FDF according to molecular ,eight
shows

two

molecular

weight

ranges of activity: FDFI000 d and

10,000FDF30,000 d. The finding that FDF I,000 daltons have activity is
in good agreement with other studies showing that peptides of molecular

weight in the range of 500 daltons are able to bind to cell surface receptors
and inhibit cell function. 67

The total lack of activity seen in the 1,000-

I0,000 molecular weight range would argue against any non specific effects
of small peptides on the cells. Present experiments performed to investigate
the susceptibility of FDF to a non specific protease have not demonstrated

protease sensitivity. This may be due to a lack of peptide bond susceptibility
in the peptide(s) that accont for FDF activity.

Finally, antibody blocking

experiments support the fibrinogen related identity of the FDF activity

response for suppressing

PMN-H20 2

production i_n vitro. Data presented here

strongly suggests that the PMN inhibitory activity demonstrated is fibrinogen
related and that significant activity is found MWI,000. These data suggest
that small molecular weight peptides of fibrinogen can inhibit PMN function

i_.n v.i.tro and may regulate PMN function in vivo. The exact identity of these
peptides remains to be determined.
Conclusion
The ability of FDF to inhibit functions related to host defense may have

important immunoregulatory and immunopathologic consequences.

FDF

inhibition of chemotaxis may inhibit the host’s initial response to microbial

invasion. Increased fibrinolytic activity found surrounding tumors may inhibit
recruitment of PMN to the tumor site, and subsequent killing of tumor cells.

Moreover, work done by other investigators in Dr. Kreutzer’s lab, using
peptides identical to those used in present experiments, has demonstrated the
ability of FDF to inhibit endothelial cell migration.

Therefore, FDF may

affect other diverse cellular kinetic processes such as angiogenesis and
neovascularizations and embryogenesis.

FDF inhibition of phagocytosis and killing of microorganisms may
affect the course and severity of diseases of microbial etiology. Bacterial
virulence factors in combination with FDF may act to favor bacterial

proliferation over host defenses. Phagocytosis is important in wound healing.

Therefore, FDF may inhibit the ability of the host to repair damage once it
has occurred.
The finding that FDF preferentially stinulate primary granules and

inhibit secondary granule release may affect PMN extracellular release of

proteases into host tissues in vivo. The increase in release of primary granule
contitutents such as elastase may cause increased connective tissue
destruction.

Currently, the mechanism(s) of action of FDF is unknown but we have
developed preliminary data to suggest that one possible mechanism for FDF

induced suppression of PMN function may involve adhesion dependent
functions.

The ability of small molecular weight peptides derived from

fibrinogen degradation to up-regulate the cell adhesive protein LFA-I is
interesting in light of recent work done with fibronectin. The peptide x-ArgGly-Asp-y which represents the putative cell binding site of fibronectin, has
been found to bind to a number of cell surface receptors inhibiting cellular

function.67

The sequence x-Arg-Gly-Asp-y has been shown to: inhibit

adhesion, spreading, and microfilament organization on fibrinogen coated
surfaces 16 inhibit experimental mettasis f murine melanoma cells 32
block neural crest cell migration 33 and bind to the platelet fibrinogen

receptor lib-Ilia inhibiting platelet interactions with that molecule. 58

The platelet fibrinogen receptor has been identified on PMN 8 and is

believed to function in adhesion. Moreover, the platelet fibrinogen receptor
lib-Ilia is thought to belong to a family of cell surface adhesion receptors

(LFA-I, M O-I) involved in cell locomotion and phagocytosis 34. Therefore, an
adhesive molecule has been described on PMN which binds fibrinogen and
whose function is blocked by small peptides derived from a matrix protein.

Experimental evidence pertaining to the Arg-Gly-Asp peptide is

particularly relevant because: l) the sequence is found twice in the c chain
of fibrinogen, 2) the sequence Arg-Gly-Asp is found in the complement

component C3, I6 3) small peptides related to fibrinogen and fibronectin are
able to bind to cell surface receptors inhibiting function in many cells. 67 It

is possible that small peptides (FDF) regulate cell function by occupying

tissue matrix binding sites and opsonin receptors on PMN during the

inflammatory processes. This process would provide an opportunity for local
control of an inflammatory lesion and provide a mechanism by ,hich

pathogens could take advantage of local regulatory processes to promote
their proliferation and tissue invasion.

Thus data obtained from this study provide a variety of interesting

avenues of investigation. For example, the identification of specific peptides
which inhibit cell function and the receptors involved will provide new

insights into the regulation of local and systemic immune function.

In

addition, the identification of specific factors that inhibit cell migration etc.

may provide exciting therapeutic possibilities. These agents may be used
therapeutically to control the repopulation of wounds by specific cell types
and

affect wound

healing

(e.g. periodontal attachment procedures).
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Moreover, development of inhibitors of cell movement may prevent and
thereby limit PMN-mediated tissue damage (e.g. rheumatoid arthritis).

Finally, the characterization of the biologic significance of specific

FDF will be instrumental in diagnosis and treatment of inflammatory diseases
such as periodontal disease.

Therefore, in the future, investigation into the role of these peptides in
biologic systems will provide the clinician as well as the basic scientist with
new and exciting areas of research.
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